Additional file 1 of Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014–2016

Autor: Espenhain, Laura, Jørgensen, Silje Bakken, Leegaard, Truls Michael, Lelek, Michaela Marie, Hänsgen, Siri Haug, Nakstad, Britt, Sunde, Marianne, Steinbakk, Martin

Countries of Asia and number of participants who have travelled there (n = 747). (DOCX 29 kb)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c24ec0d5579a5b871ffc1a8b960632a

Travel to Asia is a strong predictor for Carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014-2016

Autor: Espenhain, Laura Elisabeth, Jørgensen, Silje Bakken, Leegaard, Truls Michael, Lelek, Michaela Marie, Hänsgen, Siri Haug, Nakstad, Britt, Sunde, Marianne, Steinbakk, Martin

Externí odkaz: https://hdl.handle.net/11250/3008251

Impact of an antibiotic policy on antibiotic use in a paediatric department. Individual based follow-up shows that antibiotics were chosen according to diagnoses and bacterial findings

Autor: Berild, Dag ^*, Ringertz, Signe Holta, Aabyholm, Gunnar, Lelek, Michaela, Fosse, Brita

Publikováno v: In International Journal of Antimicrobial Agents 2002 20(5):333-338

Appropriate Antibiotic Use According to Diagnoses and Bacteriological Findings: Report of 12 Point-prevalence Studies on Antibiotic Use in a University Hospital.

Autor: Berild, Dag, Ringertz, Signe Holta, Lelek, Michaela

Publikováno v: Scandinavian Journal of Infectious Diseases; Jan2002, Vol. 34 Issue 1, p56-60, 5p, 3 Charts, 1 Graph

Travel to Asia is a strong predictor for carriage of cephalosporin resistant E. coli and Klebsiella spp. but does not explain everything; prevalence study at a Norwegian hospital 2014-2016.

Autor: Espenhain L; 1Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213 Oslo, NO Norway.; 2European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden., Jørgensen SB; 3Department of Clinical Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Leegaard TM; 3Department of Clinical Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway.; 4Institute for Clinical Medicine, Campus Ahus, University of Oslo, Nordbyhagen, Norway., Lelek MM; 3Department of Clinical Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Hänsgen SH; 3Department of Clinical Microbiology and Infection Control, Akershus University Hospital, Lørenskog, Norway., Nakstad B; 4Institute for Clinical Medicine, Campus Ahus, University of Oslo, Nordbyhagen, Norway.; 5Department of Paediatrics and Adolescents Medicine, Akershus University Hospital, Lørenskog, Norway., Sunde M; 6Department of Molecular Biology, Norwegian Institute of Public Health, Oslo, Norway.; 7Section for Food Safety and Emerging Health Threats, Norwegian Veterinary Institute, Nordbyhagen, Norway., Steinbakk M; 1Department of Antibiotic Resistance and Infection Prevention, Norwegian Institute of Public Health, PO Box 222 Skøyen, 0213 Oslo, NO Norway.

Publikováno v: Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2018 Nov 29; Vol. 7, pp. 146. Date of Electronic Publication: 2018 Nov 29 (Print Publication: 2018).